Geoff Birkett
2023
In 2023, Geoff Birkett earned a total compensation of $392.4K as Chief Commercial Officer at Ensysce Biosciences, a 7% increase compared to previous year.
Compensation breakdown
Option Awards | $70,350 |
---|---|
Salary | $312,625 |
Other | $9,379 |
Total | $392,354 |
Birkett received $312.6K in salary, accounting for 80% of the total pay in 2023.
Birkett also received $70.4K in option awards and $9.4K in other compensation.
Rankings
In 2023, Geoff Birkett's compensation ranked 2,288th out of 2,978 executives tracked by ExecPay. In other words, Birkett earned more than 23.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,288 | 23rd |
Manufacturing | 1,288 | 21st |
Chemicals And Allied Products | 762 | 16th |
Drugs | 743 | 15th |
Pharmaceutical Preparations | 534 | 15th |
Birkett's colleagues
We found two more compensation records of executives who worked with Geoff Birkett at Ensysce Biosciences in 2023.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021